Actively Recruiting

Phase Not Applicable
Age: 25Years - 65Years
All Genders
ID07235358

Glycemic Effects of Substituting Pecans for Snacks Higher in Saturated Fat and Added Sugars in Individuals With Prediabetes

Led by Penn State University · Updated on 2026-05-27

147

Participants Needed

1

Research Sites

N/A

Total Duration

On this page

Sponsors

P

Penn State University

Lead Sponsor

A

American Pecan Promotion Board

Collaborating Sponsor

AI-Summary

What this Trial Is About

Researchers are evaluating the impact of replacing snacks higher in saturated fats and added sugars with pecans on blood sugar control, heart health, and diet quality in adults with prediabetes. This 16-week randomized controlled trial compares two groups to understand how pecan snacking affects these health factors in individuals aged 25 to 65 years who have prediabetes and meet specific health criteria. Participants will be randomly assigned to one of two groups. One group will replace their usual snacks with 1.5 ounces of pecans daily, while the other group will continue their habitual diet. Both groups will be followed for 16 weeks, with the pecan group receiving pecans and the usual diet group receiving a grocery voucher of similar value. Testing will occur at the start and end of the study period to measure changes. Throughout the study, participants will undergo assessments including blood sugar tests (such as HbA1c), heart health evaluations, and dietary intake reviews at baseline and after 16 weeks. Researchers will monitor various health markers such as glucose levels, cholesterol, blood pressure, insulin resistance, and diet quality. The study aims to gather detailed information on how pecan snacking influences these outcomes, with safety and adherence closely observed during the 16-week participation.

CONDITIONS

Brief Title

Cardiometabolic Effects of Pecan Snacking in Prediabetes

Who Can Participate

Age: 25Years - 65Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Age 25 to 65 years
  • Prediabetes with HbA1c between 5.7% and 6.4% at screening
  • Body mass index (BMI) between 25 and 40 kg/m2 at screening
  • Low usual nut consumption (less than 3.5 oz-equivalents per week)
  • Regular consumption of snacks higher in saturated fat and/or added sugars
Not Eligible

You will not qualify if you...

  • LDL cholesterol 190 mg/dL or higher at screening
  • Hemoglobin less than 13.2 g/dL at screening
  • Fasting triglycerides over 350 mg/dL at screening
  • Body weight changed by 10% or more in the past 6 months
  • Blood pressure higher than 140/90 mmHg at screening
  • Diagnosis of type 1 or type 2 diabetes
  • Use of anti-hypertensive, lipid-lowering, or glucose-lowering medications
  • Use of supplements or over-the-counter medications affecting lipids, blood pressure, or glucose and unwilling to stop during the study
  • History of liver, kidney, or autoimmune disease
  • Prior cardiovascular event such as stroke or heart attack
  • Current pregnancy or planning pregnancy within 12 months
  • Breastfeeding within the past 6 months
  • Allergy, intolerance, sensitivity, or dislike of pecans
  • Unable or unwilling to eat 1.5 oz of pecans daily
  • Antibiotic or oral steroid use within the past 4 weeks
  • Use of tobacco or nicotine products in the past 6 months
  • History of cancer in the past 10 years (except non-melanoma skin cancer without recurrence for 5 years)
  • Participation in another clinical trial within 60 days
  • Unwillingness to avoid other health-related research during the study
  • Following a restricted or weight-loss diet
  • Prior bariatric surgery
  • Intake of more than 14 alcoholic drinks per week or unwillingness to avoid alcohol 48 hours before tests
  • Weight less than 110 pounds
  • Abnormal thyroid hormone levels or medication changes in the past 6 months
  • Does not speak or understand English
  • Unwilling to avoid donating blood or plasma during the study
  • Investigator's judgment on ability to adhere to study requirements

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 visit (in-person)

Outpatient Treatment

Duration - 16 weeks

Participants replace their usual snacks higher in saturated fat and added sugars with 1.5 oz/day of pecans or continue their habitual diet.

1 baseline visit and 1 follow-up visit

Trial Site Locations

Total: 1 location

1

The Pennsylvania State University

University Park, Pennsylvania, United States, 16802

Actively Recruiting

Loading map...

Research Team

K

Kristina Petersen, PhD

S

Stacey Meily

How is the study designed?

Study Type

INTERVENTIONAL

Masking

SINGLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

PREVENTION

Number of Arms

2

Similar Trials

A Randomized Comparison of Cleerly Coronary Artery Disease S...

Diabetes Mellitus, Type 2

Actively Recruiting

124 locations

A Randomized, Open-label Clinical Trial Comparing Semaglutid...

Coronary Artery Disease

Actively Recruiting

1 location

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here